Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

Tag: C-bridge capital

Chinese Healthcare-Focused C-Bridge Capital Gets $50M From US Public Pension Fund

Eudora Wang -

C-Bridge Capital Leads Series B Round In Chinese Pharmaceutical Firm Nuance...

Yimian Wu -

Chinese Biotech Firm Ascletis First To File For Hong Kong IPO...

Violet Tang -

C-Bridge Capital, BioBAY Lead $38M Series A Round In Biopharmaceutical Service...

Yimian Wu -

China Healthcare Investor Forum 2017

Katherine Guo -

C-Bridge Closes Its Second Healthcare Fund At $400M

Pan Yue -

Qiming Leads $29M Round In Chinese Antibody Drug Developer Sino Biological

Pan Yue -

CICC, CITIC To Privatize Chinese Biopharma Firm Sinovac Biotech

Pan Yue -

Sinovac Biotech Ltd. Enters into Definitive Agreement for Going-Private Transaction

Syndicated Press Releases -

C-Bridge Capital Leads $150M Round In Merged Chinese Drug Developer

Pan Yue -

C-Bridge’s Fu Wei Aims To Profit By Transferring Pharma Tech To...

Nina Xiang -

C-Bridge Invests $25M In Medical Equipment Maker Anrei

Nina Xiang -

C-Bridge Capital Leads $100M Round In Chinese Drug Start-Up Ascletis

Li Dongmei -

Goldman Sachs Injects $20M In China Biotech Firm Ascletis

Jillian Yue -

C-Bridge Capital Leads $35M New Round In Ascletis

Investment Research Team -
China Expert network
© 2020 China Money Network Limited. All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.